UNAUDITED FINANCIAL RESULTS - 30.06.2026.
RESULTS
▲ Positive Development
LOW RISK
📅 Filed on BSE: 27 Jul 2026, 01:54 PM IST · BSE ID: 0ae73118-f7bd-4864-b1ea-5781d48d0ba5
View Original BSE Filing (PDF)
💡
In Simple Terms
Epigral Ltd announced its first quarter financial results for FY26, with a standalone net profit of Rs. 99.18 Crore.
🤖 AI Summary
- Epigral Ltd reported Unaudited Standalone Net Profit of Rs. 99.18 Crore for Q1 FY26.
- Standalone Revenue from operations stood at Rs. 705.36 Crore for the quarter ended June 30, 2026.
- Basic Earnings Per Share (Standalone) for Q1 FY26 was Rs. 22.99.
- The Board approved both Unaudited Standalone and Consolidated Financial Results for Q1 FY26.
- Total Standalone expenses were Rs. 576.28 Crore for the quarter.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Standalone Revenue from operations (3 months ended June 30, 2026)
705.36 Crore
Standalone Profit after tax (3 months ended June 30, 2026)
99.18 Crore
Standalone Basic Earnings per share (3 months ended June 30, 2026)
22.99 rupees
Consolidated Revenue from operations (3 months ended June 30, 2026)
705.36 Crore
Consolidated Profit after tax (3 months ended June 30, 2026)
99.74 Crore
Consolidated Basic Earnings per share (3 months ended June 30, 2026)
23.12 rupees
🏢 How This Affects the Company
The company's revenue from operations for Q1 FY26 was Rs. 705.36 Crore, indicating continued business activity in its 'Chiaro Alkali & its Derivatives' segment. A wholly-owned subsidiary, Epigral Advanced Material Limited, was incorporated on July 07, 2026, to expand into chemical manufacturing.
Standalone Profit After Tax for Q1 FY26 was Rs. 99.18 Crore. Consolidated Profit After Tax was Rs. 99.74 Crore. The company opted for the reduced income tax rate under Section 115BAA of the Income tax Act, 1961, effective from FY25-26, which included a one-time deferred tax credit of Rs. 80.87 Crore in the prior year.
The incorporation of a new wholly-owned subsidiary, Epigral Advanced Material Limited, suggests an expansion of manufacturing capabilities and product lines within the chemicals sector.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required by shareholders based on this financial results filing.
👤
Who Is Affected
All shareholders are affected by the company's financial performance, specifically the Profit after tax of Rs. 99.18 Crore and Earnings per share of Rs. 22.99 for Q1 FY26.
🔍
Management Signal
The management's decision to incorporate a new wholly-owned subsidiary, Epigral Advanced Material Limited, signals an intent for business expansion into new chemical manufacturing areas.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Q2 FY26 financial results — check revenue and profit trends.
Updates on operations of Epigral Advanced Material Limited.
Progress of the 19.80 MW Wind Solar Hybrid Power plant in Gujarat.
LOW RISK
The filing indicates stable operational results and a planned subsidiary for expansion.
💡 Investor Takeaway
Epigral Ltd recorded a Standalone Profit after tax of Rs. 99.18 Crore for the quarter ended June 30, 2026. Revenue from operations was Rs. 705.36 Crore. The Board also approved the incorporation of a wholly-owned subsidiary, Epigral Advanced Material Limited, on July 07, 2026, for chemical manufacturing.
⚖️ Strengths & Concerns
✅ Positives
- Standalone Profit after tax of Rs. 99.18 Crore for Q1 FY26, an increase from Rs. 81.93 Crore in the preceding quarter.
- Revenue from operations at Rs. 705.36 Crore in Q1 FY26, up from Rs. 606.54 Crore in the corresponding quarter of the previous year.
⚠️ Concerns
- Standalone Profit after tax of Rs. 99.18 Crore for Q1 FY26 decreased from Rs. 160.41 Crore in the corresponding quarter of the previous year.
- Finance costs were Rs. 7.22 Crore for Q1 FY26, while remaining high at Rs. 71.96 Crore for the full year ended March 31, 2026.
📅 Company Track Record
Epigral Ltd's Q1 FY26 standalone net profit of Rs. 99.18 Crore follows a standalone net profit of Rs. 99.18 Crore for Q1 FY26, as previously intimated on July 27, 2026. This also follows the Board meeting held on July 27, 2026, which was intimated on July 22, 2026, to approve the Q1 FY26 results.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What was Epigral Ltd's standalone net profit in Q1 FY26?
Epigral Ltd's Unaudited Standalone Profit after tax for the quarter ended June 30, 2026, was Rs. 99.18 Crore.
What was Epigral Ltd's standalone revenue from operations in Q1 FY26?
Epigral Ltd's Standalone Revenue from operations for the quarter ended June 30, 2026, was Rs. 705.36 Crore.
What was Epigral Ltd's basic earnings per share in Q1 FY26?
Epigral Ltd's Standalone Basic Earnings per share for the quarter ended June 30, 2026, was Rs. 22.99.
What new subsidiary has Epigral Ltd incorporated?
Epigral Ltd has incorporated a wholly-owned subsidiary named 'Epigral Advanced Material Limited' on July 07, 2026, with the objective of manufacturing chemicals.
What was Epigral Ltd's consolidated net profit in Q1 FY26?
Epigral Ltd's Unaudited Consolidated Profit after tax for the quarter ended June 30, 2026, was Rs. 99.74 Crore.
Questions based on this BSE filing only. For information purposes.